Portfolio Holdings Detail for ISIN IE000R9FA4A0
Stock Name / Fund iShares S&P 500 ESG UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares III Public Limited Company
Entity Type
Entity LEI 549300PZLRJB7M8H1057
ETF Ticker ESPX(USD) AS
ETF Ticker ESPX(USD) Euronext Amsterdam

Holdings detail for REGN

Stock Name	Regeneron Pharmaceuticals Inc
Ticker	REGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US75886F1075
LEI	549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria: (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages: Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL: Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors: Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN: In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC: Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.: Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.: D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares S&P 500 ESG UCITS ETF USD (Acc) REGN holdings

Date	Number of REGN Shares Held	Base Market Value of REGN Shares	Local Market Value of REGN Shares	Change in REGN Shares Held	Change in REGN Base Value	Current Price per REGN Share Held	Previous Price per REGN Share Held
2025-12-03 (Wednesday)	2,045	USD 1,479,905	USD 1,479,905	0	USD -37,485	USD 723.67	USD 742
2025-12-02 (Tuesday)	2,045	USD 1,517,390	USD 1,517,390	0	USD -16,585	USD 742	USD 750.11
2025-12-01 (Monday)	2,045	USD 1,533,975	USD 1,533,975	0	USD -61,514	USD 750.11	USD 780.19
2025-11-28 (Friday)	2,045	USD 1,595,489	USD 1,595,489	0	USD -9,038	USD 780.19	USD 784.61
2025-11-27 (Thursday)	2,045	USD 1,604,527	USD 1,604,527	0	USD 0	USD 784.61	USD 784.61
2025-11-26 (Wednesday)	2,045	USD 1,604,527	USD 1,604,527	0	USD -5,542	USD 784.61	USD 787.32
2025-11-25 (Tuesday)	2,045	USD 1,610,069	USD 1,610,069	0	USD 52,904	USD 787.32	USD 761.45
2025-11-24 (Monday)	2,045	USD 1,557,165	USD 1,557,165	0	USD 50,000	USD 761.45	USD 737
2025-11-20 (Thursday)	2,045	USD 1,507,165	USD 1,507,165	0	USD 70,041	USD 737	USD 702.75
2025-11-19 (Wednesday)	2,045	USD 1,437,124	USD 1,437,124	0	USD -46,196	USD 702.75	USD 725.34
2025-11-18 (Tuesday)	2,045	USD 1,483,320	USD 1,483,320	0	USD 43,006	USD 725.34	USD 704.31
2025-11-17 (Monday)	2,045	USD 1,440,314	USD 1,440,314	9	USD 28,348	USD 704.31	USD 693.5

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE000R9FA4A0

Show aggregate share trades of REGN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-17 BUY 9 711.880 692.290 694.249 USD 6,248 635.29
2025-11-13 SELL -18 713.580 679.930 683.295 USD -12,299 634.73 Loss of -874 on sale
2025-11-07 BUY 27 657.530* 634.10
2025-11-03 BUY 27 657.460 627.500 630.496 USD 17,023 633.98
2025-10-17 SELL -18 578.050 579.040 578.941 USD -10,421 635.56 Profit of 1,019 on sale
2025-10-15 BUY 18 576.420 584.870 584.025 USD 10,512 636.23
2025-10-07 BUY 9 583.240 591.450 590.629 USD 5,316 637.21
2025-09-24 BUY 63 576.980 577.980 577.880 USD 36,406 639.67
2025-09-16 SELL -27 575.060 579.400 578.966 USD -15,632 640.58 Profit of 1,664 on sale
2025-09-11 SELL -27 568.200 570.760 570.504 USD -15,404 641.86 Profit of 1,927 on sale
2025-08-29 BUY 36 580.700 581.250 581.195 USD 20,923 642.57
2025-08-06 BUY 9 555.130 573.470 571.636 USD 5,145 643.96
2025-07-31 BUY 54 545.460 558.130 556.863 USD 30,071 645.52
2025-07-22 BUY 9 560.930 563.000 562.793 USD 5,065 649.23
2025-07-14 SELL -9 570.590 575.130 574.676 USD -5,172 653.12 Profit of 706 on sale
2025-07-02 BUY 9 547.740 551.500 551.124 USD 4,960 658.79
2025-06-30 BUY 27 525.000 526.080 525.972 USD 14,201 659.73
2025-06-27 BUY 45 521.000 531.210 530.189 USD 23,859 660.71
2025-06-26 BUY 18 521.000 524.520 524.168 USD 9,435 661.70
2025-06-18 SELL -9 513.580 519.170 518.611 USD -4,667 668.21 Profit of 1,346 on sale
2025-06-17 SELL -45 508.860 523.010 521.595 USD -23,472 669.39 Profit of 6,651 on sale
2025-06-13 BUY 63 529.240 529.550 529.519 USD 33,360 671.57
2025-06-05 BUY 9 483.070 491.770 490.900 USD 4,418 679.28
2025-05-30 BUY 54 490.280 519.780 516.830 USD 27,909 685.53
2025-05-22 SELL -18 596.850 605.500 604.635 USD -10,883 689.31 Profit of 1,524 on sale
2025-05-19 BUY 90 596.540 598.560 598.358 USD 53,852 691.52
2025-05-16 BUY 9 594.320 595.190 595.103 USD 5,356 692.38
2025-05-14 BUY 9 571.360 580.560 579.640 USD 5,217 694.44
2025-05-01 SELL -9 590.000 593.930 593.537 USD -5,342 705.29 Profit of 1,006 on sale
2025-04-23 BUY 27 587.850 603.770 602.178 USD 16,259 712.19
2025-04-17 BUY 9 563.160 564.210 564.105 USD 5,077 718.45
2025-04-11 BUY 50 554.180 555.530 555.395 USD 27,770 725.73
2025-04-07 SELL -63 572.780 591.540 589.664 USD -37,149 733.47 Profit of 9,060 on sale
2025-04-04 SELL -81 573.450 612.990 609.036 USD -49,332 735.40 Profit of 10,236 on sale
2025-03-21 SELL -9 658.480 661.000 660.748 USD -5,947 747.22 Profit of 778 on sale
2025-03-18 SELL -36 664.960 678.270 676.939 USD -24,370 750.63 Profit of 2,653 on sale
2025-03-17 SELL -90 678.420 679.830 679.689 USD -61,172 751.66 Profit of 6,477 on sale
2025-03-13 SELL -18 680.610 698.950 697.116 USD -12,548 753.95 Profit of 1,023 on sale
2025-03-11 BUY 39 718.160 747.700 744.746 USD 29,045 755.47
2025-03-10 SELL -9 744.830 748.290 747.944 USD -6,731 755.64 Profit of 69 on sale
2025-03-05 SELL -27 687.150 692.790 692.226 USD -18,690 758.44 Profit of 1,788 on sale
2025-03-03 SELL -9 684.870 704.640 702.663 USD -6,324 761.05 Profit of 525 on sale
2025-02-21 SELL -32 700.330 704.080 703.705 USD -22,519 766.99 Profit of 2,025 on sale
2025-02-14 SELL -36 673.600 684.000 682.960 USD -24,587 775.68 Profit of 3,338 on sale
2025-02-12 SELL -45 663.860 670.980 670.268 USD -30,162 780.22 Profit of 4,948 on sale
2025-02-10 BUY 9 690.360 719.780 716.838 USD 6,452 784.77
2025-02-05 BUY 123 716.720 729.250 727.997 USD 89,544 789.66
2025-02-03 BUY 18 666.850 673.650 672.970 USD 12,113 795.05
2025-01-31 BUY 81 672.980 688.000 686.498 USD 55,606 798.18
2025-01-29 BUY 45 687.270 697.570 696.540 USD 31,344 804.28
2025-01-28 BUY 8 686.330 690.300 689.903 USD 5,519 807.56
2025-01-24 BUY 9 675.790 693.840 692.035 USD 6,228 815.05
2024-12-09 BUY 8 788.000 800.990 799.691 USD 6,398 820.98
2024-12-06 BUY 117 778.000 778.120 778.108 USD 91,039 822.42
2024-12-03 BUY 36 749.570 770.000 767.957 USD 27,646 829.66
2024-12-02 BUY 9 762.340 763.890 763.735 USD 6,874 832.25
2024-11-29 BUY 9 750.220 754.510 754.081 USD 6,787 835.53
2024-11-08 BUY 63 828.420 830.730 830.499 USD 52,321 892.43
2024-10-31 SELL -17 838.200 883.150 878.655 USD -14,937 939.11 Profit of 1,028 on sale
2024-10-30 BUY 9 922.790 935.860 934.553 USD 8,411 941.44
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-17	BUY	9	711.880	692.290	694.249	USD 6,248	635.29
2025-11-13	SELL	-18	713.580	679.930	683.295	USD -12,299	634.73 Loss of -874 on sale
2025-11-07	BUY	27			657.530*		634.10
2025-11-03	BUY	27	657.460	627.500	630.496	USD 17,023	633.98
2025-10-17	SELL	-18	578.050	579.040	578.941	USD -10,421	635.56 Profit of 1,019 on sale
2025-10-15	BUY	18	576.420	584.870	584.025	USD 10,512	636.23
2025-10-07	BUY	9	583.240	591.450	590.629	USD 5,316	637.21
2025-09-24	BUY	63	576.980	577.980	577.880	USD 36,406	639.67
2025-09-16	SELL	-27	575.060	579.400	578.966	USD -15,632	640.58 Profit of 1,664 on sale
2025-09-11	SELL	-27	568.200	570.760	570.504	USD -15,404	641.86 Profit of 1,927 on sale
2025-08-29	BUY	36	580.700	581.250	581.195	USD 20,923	642.57
2025-08-06	BUY	9	555.130	573.470	571.636	USD 5,145	643.96
2025-07-31	BUY	54	545.460	558.130	556.863	USD 30,071	645.52
2025-07-22	BUY	9	560.930	563.000	562.793	USD 5,065	649.23
2025-07-14	SELL	-9	570.590	575.130	574.676	USD -5,172	653.12 Profit of 706 on sale
2025-07-02	BUY	9	547.740	551.500	551.124	USD 4,960	658.79
2025-06-30	BUY	27	525.000	526.080	525.972	USD 14,201	659.73
2025-06-27	BUY	45	521.000	531.210	530.189	USD 23,859	660.71
2025-06-26	BUY	18	521.000	524.520	524.168	USD 9,435	661.70
2025-06-18	SELL	-9	513.580	519.170	518.611	USD -4,667	668.21 Profit of 1,346 on sale
2025-06-17	SELL	-45	508.860	523.010	521.595	USD -23,472	669.39 Profit of 6,651 on sale
2025-06-13	BUY	63	529.240	529.550	529.519	USD 33,360	671.57
2025-06-05	BUY	9	483.070	491.770	490.900	USD 4,418	679.28
2025-05-30	BUY	54	490.280	519.780	516.830	USD 27,909	685.53
2025-05-22	SELL	-18	596.850	605.500	604.635	USD -10,883	689.31 Profit of 1,524 on sale
2025-05-19	BUY	90	596.540	598.560	598.358	USD 53,852	691.52
2025-05-16	BUY	9	594.320	595.190	595.103	USD 5,356	692.38
2025-05-14	BUY	9	571.360	580.560	579.640	USD 5,217	694.44
2025-05-01	SELL	-9	590.000	593.930	593.537	USD -5,342	705.29 Profit of 1,006 on sale
2025-04-23	BUY	27	587.850	603.770	602.178	USD 16,259	712.19
2025-04-17	BUY	9	563.160	564.210	564.105	USD 5,077	718.45
2025-04-11	BUY	50	554.180	555.530	555.395	USD 27,770	725.73
2025-04-07	SELL	-63	572.780	591.540	589.664	USD -37,149	733.47 Profit of 9,060 on sale
2025-04-04	SELL	-81	573.450	612.990	609.036	USD -49,332	735.40 Profit of 10,236 on sale
2025-03-21	SELL	-9	658.480	661.000	660.748	USD -5,947	747.22 Profit of 778 on sale
2025-03-18	SELL	-36	664.960	678.270	676.939	USD -24,370	750.63 Profit of 2,653 on sale
2025-03-17	SELL	-90	678.420	679.830	679.689	USD -61,172	751.66 Profit of 6,477 on sale
2025-03-13	SELL	-18	680.610	698.950	697.116	USD -12,548	753.95 Profit of 1,023 on sale
2025-03-11	BUY	39	718.160	747.700	744.746	USD 29,045	755.47
2025-03-10	SELL	-9	744.830	748.290	747.944	USD -6,731	755.64 Profit of 69 on sale
2025-03-05	SELL	-27	687.150	692.790	692.226	USD -18,690	758.44 Profit of 1,788 on sale
2025-03-03	SELL	-9	684.870	704.640	702.663	USD -6,324	761.05 Profit of 525 on sale
2025-02-21	SELL	-32	700.330	704.080	703.705	USD -22,519	766.99 Profit of 2,025 on sale
2025-02-14	SELL	-36	673.600	684.000	682.960	USD -24,587	775.68 Profit of 3,338 on sale
2025-02-12	SELL	-45	663.860	670.980	670.268	USD -30,162	780.22 Profit of 4,948 on sale
2025-02-10	BUY	9	690.360	719.780	716.838	USD 6,452	784.77
2025-02-05	BUY	123	716.720	729.250	727.997	USD 89,544	789.66
2025-02-03	BUY	18	666.850	673.650	672.970	USD 12,113	795.05
2025-01-31	BUY	81	672.980	688.000	686.498	USD 55,606	798.18
2025-01-29	BUY	45	687.270	697.570	696.540	USD 31,344	804.28
2025-01-28	BUY	8	686.330	690.300	689.903	USD 5,519	807.56
2025-01-24	BUY	9	675.790	693.840	692.035	USD 6,228	815.05
2024-12-09	BUY	8	788.000	800.990	799.691	USD 6,398	820.98
2024-12-06	BUY	117	778.000	778.120	778.108	USD 91,039	822.42
2024-12-03	BUY	36	749.570	770.000	767.957	USD 27,646	829.66
2024-12-02	BUY	9	762.340	763.890	763.735	USD 6,874	832.25
2024-11-29	BUY	9	750.220	754.510	754.081	USD 6,787	835.53
2024-11-08	BUY	63	828.420	830.730	830.499	USD 52,321	892.43
2024-10-31	SELL	-17	838.200	883.150	878.655	USD -14,937	939.11 Profit of 1,028 on sale
2024-10-30	BUY	9	922.790	935.860	934.553	USD 8,411	941.44

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	208,659	1,635	312,812	66.7%
2025-09-18	236,485	3,679	387,519	61.0%
2025-09-17	229,191	716	370,895	61.8%
2025-09-16	173,632	584	271,020	64.1%
2025-09-15	204,491	251	334,496	61.1%
2025-09-12	117,504	33	222,760	52.7%
2025-09-11	125,478	3,137	286,516	43.8%
2025-09-10	195,068	481	339,885	57.4%
2025-09-09	129,168	994	274,520	47.1%
2025-09-08	250,895	396	527,062	47.6%
2025-09-05	170,149	290	289,566	58.8%
2025-09-04	188,227	2,103	360,619	52.2%
2025-09-03	185,679	344	438,111	42.4%
2025-09-02	191,954	138	476,288	40.3%
2025-08-29	133,226	685	236,726	56.3%
2025-08-28	116,560	2,177	256,675	45.4%
2025-08-27	113,719	465	243,836	46.6%
2025-08-26	210,376	450	400,199	52.6%
2025-08-25	149,130	68	363,377	41.0%
2025-08-22	211,822	3,244	701,770	30.2%
2025-08-21	257,492	3,416	446,439	57.7%
2025-08-20	327,738	572	559,133	58.6%
2025-08-19	118,472	2,191	324,311	36.5%
2025-08-18	146,282	388	277,909	52.6%
2025-08-15	209,923	3,375	441,752	47.5%
2025-08-14	157,569	3,623	429,327	36.7%
2025-08-13	111,342	233	362,786	30.7%
2025-08-12	117,647	171	310,775	37.9%
2025-08-11	129,513	2,676	284,757	45.5%
2025-08-08	128,559	1,038	431,841	29.8%
2025-08-07	166,648	1,560	352,877	47.2%
2025-08-06	176,311	624	397,089	44.4%
2025-08-05	154,257	115	353,744	43.6%
2025-08-04	200,758	1,913	409,897	49.0%
2025-08-01	349,775	3,745	728,720	48.0%
2025-07-31	222,350	476	549,344	40.5%
2025-07-30	106,839	1,689	231,761	46.1%
2025-07-29	149,359	276	292,667	51.0%
2025-07-28	103,687	1,380	245,287	42.3%
2025-07-25	103,783	556	259,069	40.1%
2025-07-24	156,974	2,397	291,677	53.8%
2025-07-23	168,734	1,708	355,372	47.5%
2025-07-22	116,324	617	304,880	38.2%
2025-07-21	98,482	900	250,107	39.4%
2025-07-18	183,174	1,051	391,909	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.